VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 122 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $16,227 | +10.3% | 1,743 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $14,711 | +8.9% | 1,743 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $13,508 | -32.3% | 1,743 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,957 | -79.3% | 1,743 | -80.7% | 0.00% | -50.0% |
| Q3 2020 | $96,542 | -15.5% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,186 | +37.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,789 | -34.4% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $126,220 | -18.9% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $155,716 | -36.8% | 9,048 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $246,287 | +42.2% | 9,048 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $173,179 | +103.6% | 9,048 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $85,051 | -50.3% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $171,188 | -99.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $176,798,000 | +59.7% | 9,048 | +53.6% | 0.00% | +50.0% |
| Q1 2018 | $110,692,000 | +112851.0% | 5,891 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -57.0% | 5,891 | -46.8% | 0.00% | 0.0% |
| Q3 2017 | $228,000 | – | 11,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| GLOBEFLEX CAPITAL L P | 36,109 | $278,400 | 0.03% |